VitaNova Life Sciences (VNOV) Common Equity (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Common Equity came in at $2.1 million in Q2 2026, up 7.44% YoY from $1.9 million in Q2 2025, and up 10.62% on a QoQ basis from $1.9 million in Q1 2026.
VitaNova Life Sciences (VNOV) Common Equity (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 10 years of Common Equity data on file, last reported at $2.1 million in Q2 2026.
- Quarterly Common Equity rose 7.44% year-over-year to $2.1 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.1 million (up 7.44% YoY) and the FY2026 annual result came in at $2.1 million, up 7.44% from the prior year.
- Common Equity grew to $2.1 million in Q2 2026, from $1.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $2.1 million in Q2 2026 to a low of -$92217.0 in Q4 2023.
- A 5-year average of $791627.4 and a median of $936129.5 in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity plunged 570.21% — and 2024, when it jumped 1883.23%.
- Tracing VNOV's Common Equity over 5 years: stood at -$30253.0 in 2022, then tumbled by 204.82% to -$92217.0 in 2023, then surged by 1222.22% to $1.0 million in 2024, then jumped by 83.42% to $1.9 million in 2025, then increased by 8.04% to $2.1 million in 2026.
- The last three Common Equity figures came in at $2.1 million (Q2 2026), $1.9 million (Q1 2026), and $1.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.58 Bn | 97.42 Bn | 3.69 Bn | -4.24 Bn |
| 2 | Cencora | 61.77 Bn | 58.96 Bn | 3.61 Bn | 3.24 Bn |
| 3 | Cardinal Health | 54.17 Bn | 49.32 Bn | 2.56 Bn | -2.88 Bn |
| 4 | Henry Schein | 10.06 Bn | 9.90 Bn | 1.10 Bn | 3.82 Bn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | 180.93 Mn |
| 6 | Edap Tms | 156.12 Mn | 134.57 Mn | 7.34 Mn | -3.23 Mn |
| 7 | Accendra Health | 93.18 Mn | 85.53 Mn | 263.41 Mn | -550.94 Mn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | -110.00 Mn |
| 9 | Cosmos Health | 13.21 Mn | 10.76 Mn | 1.51 Mn | 20.67 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.05 Mn |
| Jan 31, 2026 | 1.85 Mn |
| Oct 31, 2025 | 1.90 Mn |
| Jul 31, 2025 | 1.86 Mn |
| Apr 30, 2025 | 1.91 Mn |
| Jan 31, 2025 | 1.11 Mn |
| Oct 31, 2024 | 1.03 Mn |
| Jul 31, 2024 | 1.00 Mn |
| Apr 30, 2024 | 1.06 Mn |
| Jan 31, 2024 | 870,782.00 |
| Oct 31, 2023 | -92,217.00 |
| Jul 31, 2023 | -83,462.00 |
| Apr 30, 2023 | -59,215.00 |
| Jan 31, 2023 | -54,830.00 |
| Oct 31, 2022 | -30,253.00 |
| Jul 31, 2022 | -32,854.00 |
| Apr 30, 2022 | -34,988.00 |
| Jan 31, 2022 | -8,181.00 |
| Oct 31, 2021 | -17,098.00 |
| Jul 31, 2021 | -32,107.00 |